The rate of reported adverse events was comparable in both the treatment and placebo groups.
Governor Hogan signed the bill (HB 999/SB 723) into law on May 12, making Maryland the 21st full-practice authority state in the United States.
The prompted cohort was significantly more likely to complete the vaccine series in a timely manner compared with the unprompted cohort.
A significantly greater weight decrease was observed in patients assigned to receive vitamin D compared with patients who had no supplementation.
These study findings confirm that the therapeutic silencing of IL-23 is a potential target for psoriasis prevention and management.